These results were complemented by IHC staining for the protein product of Birc5 (survivin) in the same tumours (Extended Data Fig. 6e,f), indicating that the acquisition of resistance to RMC-7977 coincided with the development of RAS–MAPK-independent expression and activity of the YAP pathway. This evidence concerns the gene BIRC5 and neoplasm.